AllSquare Wealth Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $317 | Hold |
175
| – | – | ﹤0.01% | 509 |
|
|
2025
Q1 | $355 | Buy |
+175
| New | +$355 | ﹤0.01% | 508 |
|
|
2024
Q4 | – | Sell |
-283
| Closed | -$2.76K | – | 542 |
|
|
2024
Q3 | $2.76K | Hold |
283
| – | – | ﹤0.01% | 458 |
|
|
2024
Q2 | $5.8K | Hold |
283
| – | – | ﹤0.01% | 417 |
|
|
2024
Q1 | $12.8K | Hold |
283
| – | – | 0.01% | 354 |
|
|
2023
Q4 | $13.4K | Hold |
283
| – | – | 0.01% | 344 |
|
|
2023
Q3 | $11.5K | Sell |
283
-62
| -18% | -$2.51K | 0.01% | 357 |
|
|
2023
Q2 | $105K | Hold |
345
| – | – | 0.07% | 131 |
|
|
2023
Q1 | $103K | Hold |
345
| – | – | 0.07% | 137 |
|
|
2022
Q4 | $119K | Hold |
345
| – | – | 0.08% | 123 |
|
|
2022
Q3 | $65K | Hold |
345
| – | – | 0.05% | 162 |
|
|
2022
Q2 | $73K | Buy |
345
+147
| +74% | +$31.1K | 0.05% | 162 |
|
|
2022
Q1 | $66K | Hold |
198
| – | – | 0.04% | 185 |
|
|
2021
Q4 | $64K | Sell |
198
-136
| -41% | -$44K | 0.04% | 191 |
|
|
2021
Q3 | $162K | Sell |
334
-4
| -1% | -$1.94K | 0.1% | 110 |
|
|
2021
Q2 | $157K | Sell |
338
-28
| -8% | -$13K | 0.09% | 116 |
|
|
2021
Q1 | $253K | Buy |
366
+23
| +7% | +$15.9K | 0.16% | 80 |
|
|
2020
Q4 | $254K | Buy |
343
+255
| +290% | +$189K | 0.17% | 73 |
|
|
2020
Q3 | $61K | Buy |
+88
| New | +$61K | 0.04% | 170 |
|
|
2020
Q2 | – | Sell |
-61
| Closed | -$22K | – | 465 |
|
|
2020
Q1 | $22K | Sell |
61
-52
| -46% | -$18.8K | 0.02% | 239 |
|
|
2019
Q4 | $26K | Sell |
113
-75
| -40% | -$17.3K | 0.02% | 241 |
|
|
2019
Q3 | $21K | Buy |
188
+79
| +72% | +$8.82K | 0.02% | 254 |
|
|
2019
Q2 | $19K | Hold |
109
| – | – | 0.01% | 267 |
|
|
2019
Q1 | $17K | Buy |
+109
| New | +$17K | 0.01% | 266 |
|